ArticleJournal of cancer research and clinical oncology2023

A real-world study of the efficacy and safety of furmonertinib for patients with non-small cell lung cancer with EGFR exon 20 insertion mutations.

Huanlan Sa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.